Halyard Purple Nitrile* Powder-Free Exam Gloves, Low Dermatitis Potential, Tested for Use with Chemotherapy Drugs, Fentanyl Citrate, Simulated Gastric Acid and Fentanyl in Simulated Gastric Acid

Halyard Purple Nitrile* Powder-Free Exam Gloves, Low Dermatitis Potential, Tested for Use with Chemotherapy Drugs, Fentanyl Citrate, Simulated Gastric Acid and Fentanyl in Simulated Gastric Acid are disposable devices intended for medical purposes that are worn on the examiner's hand to prevent contamination between patient and examiner.

These gloves were tested for use with the following chemotherapy drugs and Fentanyl Citrate and Gastric Acid as per ASTM -D6978-05:

The following chemotherapy drugs and concentration had NO breakthrough detected up to 240 minutes:

Azacitidine (25 mg/ml)

Bendamustine HCI (5 mg/ml)

Bleomycin Sulfate (15 mg/ml)

Bortezomib (1 mg/ml)

Busulfan (6 mg/ml)

Capecitabine (26 mg/ml)

Carboplatin (10 mg/ml)

Carlzomib (2 mg/ml)

Cetuximab (2 mg/ml)

Chloroquine (50 mg/ml)

Cisplatin (1 mg/ml)

Cladribine (1 mg/ml)

Cyclophosphamide (20 mg/ml)

Cyclosporin A (100 mg/ml)

Cytarabine (Cytosine) (100 mg/ml)

Cytovene (Ganciclovir) (10 mg/ml)

Dacarbazine (DTIC) (10 mg/ml)

Dactinomycin (0.5 mg/ml)

Daunorubicin HCI (5 mg/ml)

Decitabine (5 mg/ml)

Docetaxel (10 mg/ml)

Doxorubicin HCl (2 mg/ml)

Epirubicin HCl (Ellence) (2 mg/ml)

Etoposide (Toposar) (20 mg/ml)

Fludarabine (25 mg/ml)

5-Fluorouracil (50 mg/ml)

Fulvestrant (50 mg/ml)

Gemcitabine (38 mg/ml)

Idarubicin (1 mg/ml)

Ifosfamide (50 mg/ml)

Irinotecan HCl (20 mg/ml)

Leuprolide Acetate Salt (5 mg/ml)

Mechlorethamine HCl (1 mg/ml)

Melphalan (5 mg/ml)

Methotrexate (25 mg/ml)

Mitomycin C (0.5 mg/ml)

Mitoxantrone (2 mg/ml)

Oxaliplatin (5 mg/ml)

Paclitaxel (6 mg/ml)

Pemetrexed (25 mg/ml)

Raltitrexed (0.5 mg/ml)

Retrovir (10 mg/ml)

Rituximab (10 mg/ml)

Temsirolimus (25 mg/ml)

Topotecan HCI (1 mg/ml)

Triclosan (2 mg/ml)

Trisenox (1 mg/ml)

Vinblastine Sulfate (1 mg/ml)

Vincristine (1 mg/ml)

Vinorelbine (10 mg/ml)

Zoledronic Acid (0.8 mg/ml)

The following chemotherapy drugs and concentration showed breakthrough detected in less than 90 minutes:

Carmustine (3.3 mg/ml) No breakthrough up to 55.3 minutes.

Thiotepa (10 mg/ml) No breakthrough up to 78.8 minutes.

Warning- Not for use with Carmustine and ThioTEPA

The following hazardous drugs (opioids) and concentration had NO breakthrough detected up to 240 minutes:

Fentanyl Citrate Injection (100 mcg/2 ml)

Simulated Gastric Acid Fluid/Fentanyl Citrate Injection Mix (50/50 Solution) (50 mcg/2 ml)